UOG Journal Club: February 2012

Slides:



Advertisements
Similar presentations
UOG Journal Club: November 2011 Ultrasound prediction of miscarriage
Advertisements

UOG Journal Club: November 2012
Examples of Sound Screening:
Screening “the systematic application of a test procedure to identify individuals at sufficient risk to warrant diagnostic investigations” CVS 12wks Amniocentesis.
Prevention of Birth Defects An Overview of Primary and Secondary Strategies.
BROWN Prenatal Screening for Trisomy 21: Recent Advances and Guidelines Jacob Canick, PhD Alpert Medical School of Brown University Women & Infants Hospital.
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
Genetics and Primary Care
Intermediate methods in observational epidemiology 2008 Quality Assurance and Quality Control.
Postmortem examination of human fetal hearts at or below 20 weeks’ gestation: a comparison of high-field MRI at 9.4 T with lower-field MRI magnets and.
IN THE NAME OF GOD. CRITICALLY APPRAISED TOPIC If there is a Non-invasive prenatal testing for aneuploidies with low FPR at first trimester? If we can.
First Trimester Screening
Routine Anomaly Scan Ilse Erasmus.
Ultrasound in obstetrics III By Dr. Khattab KAEO Assis. Prof. of Obstetrics and Gynaecology Faculty of Medicine, Al-Azhar University, Damietta.
Module One: Introduction to the California Prenatal Screening Program
UOG Journal Club: April 2013 Intrapartum transperineal ultrasound assessment of fetal head progression in active second stage of labor and mode of delivery.
National Women’s Screening for Aneuploidy Dr Emma Parry CMFM Clinical Director Maternal-Fetal Medicine National Women’s Health.
In the name of god First Trimester Screening Dr.M.Moradi.
UOG Journal Club: August 2011
Epidemiological Monitoring and Quality Control of Nuchal Translucency Jack Canick Intensive Course on Screening for Down’s Syndrome Wolfson Institute of.
Follow-up scans later in pregnancy improved accreta detection but provided useful information in only a limited number of cases. Of the individual markers,
VI. Hrvatski kongres o ginekološkoj endokrinologiji, humanoj reprodukciji i menopavzi s međunarodnim sudjelovanjem , Brijuni DARIJA STRAH.
UOG Journal Club: July 2013 Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis G. Pagani, F. D’Antonio,
NHS Fetal Anomaly Screening Programme Marie Coughlin Screening Lead January 25 th 2010.
Nuchal Translucency (NT) Screen Ernest F. Talarico, Jr., Ph.D. Associate Director of Medical Education Associate Professor of Anatomy & Cell Biology Associate.
Genetic Testing in Pregnancy Lisbeth M. Lazaron, MD March 2013.
National Center for Fetal Medicine Dept. Ob–Gyn Trondheim Norway Pregnancy dating.
UOG Journal Club: January 2016 Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results.
How to image the fetal corpus callosum
UOG Journal Club: March 2016 Prediction of large-for-gestational-age neonates: screening by maternal factors and biomarkers in the three trimesters of.
UOG Journal Club: July 2013 Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies M. M. Gil, M. S. Quezada, B. Bregant,
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
Current practice of cfDNA testing
UOG Journal Club: June 2017 Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE.
Anterior Segment OCT in Strabismus
Figure 1: Classification of CNS abnormality (%)
UOG Journal Club: April 2016
UOG Journal Club: October 2017
UOG Journal Club: August 2017
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
UOG Journal Club: January 2016
UOG Journal Club: March 2016
Screening for High Risk Pregnancy Peter Hornnes
Informed Consent, Image Recording and
Ziya Kalem,MD Gurgan Clinic IVF and Women Health Center
UOG Journal Club: May 2017 Increased nuchal translucency thickness and risk of neurodevelopmental disorders S.G. Hellmuth, L.H. Pedersen, C.B. Miltoft,
UOG Journal Club: May 2017 Increased nuchal translucency thickness and risk of neurodevelopmental disorders S.G. Hellmuth, L.H. Pedersen, C.B. Miltoft,
Technical Guideline How do we do it
Jeffrey A. Kuller, MD; Sean C. Blackwell, MD
UOG Journal Club: December 2017
UOG Journal Club: September 2018
UOG Journal Club: April 2017
UOG Journal Club: July 2012 Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia A. Khalil, R. Akolekar, A. Syngelaki, M. Elkhouli.
UOG Journal Club: September 2011
Fetal Medicine Foundation fetal and neonatal population weight charts
UOG Journal Club: August 2018
UOG Journal Club: October 2018
UOG Journal Club: August 2013
UOG Journal Club: January 2019
Objectives Goals of the week scan
guidance on antenatal screening
UOG Journal Club: March 2019
The Tug of War Between Stillbirths and Elective Early Births
Ultrasound in fetal screening ( Down syndrome,…)
NON – INVASIVE PRENATAL TESTING
Intermediate methods in observational epidemiology 2008
Computed tomography topographic mapping of subchondral density (CT-TOMASD) in osteoarthritic and normal knees: methodological development and preliminary.
UOG Journal Club: March 2012
UOG Journal Club: September 2019
UOG Journal Club: October 2019
Presentation transcript:

UOG Journal Club: February 2012 Intra- and interoperator reliability of manual and semi-automated measurements of intracranial translucency K. Karl, K. O. Kagan and R. Chaoui Volume 39, Issue 2, Date: February 2012, pages 164–168 Journal Club slides prepared by Dr Asma Khalil (UOG Editor for Trainees)

Spina Bifida 3–6 per 10,000 births 3-6 per 10,000 births 5 10 15 20 25 1930s Birth prevalence (/10,000) Year 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 Prenatal diagnosis Folic acid fortification 3–6 per 10,000 births Rankin J et al., Paediatr Perinat Epidemiol 2000 Centre for Disease Control and Prevention statistics 2011 Boyd PA et al., J Med Screen 2011

Detection rate by ultrasound at 11-14 weeks is 14% Open spina Bifida Prenatal Detection History 5% MS AFP 75% Ultrasound* 98% *2nd trimester MS AFP, maternal serum alpha fetoprotein. Detection rate by ultrasound at 11-14 weeks is 14% Wald N et al., Lancet 1974 Nicolaides KH et al., Lancet 1986 Campbell J et al., Obstet Gynecol 1987 Syngelaki A et al., Prenat Diagn 2011

OB,occipital bone; Th, Thalamus. First-trimester detection of open spina bifida using intracranial translucency (IT) Normal Open spina bifida BS,brainstem; BSOB, brainstem–occipital bone distance; f.CM, future cisterna magna; OB,occipital bone; Th, Thalamus. Chaoui R et al., UOG 2011

B, brainstem;T, thalamus; M, midbrain; My, medulla oblongata. Chaoui R et al., UOG 2009

Normal Open spina bifida Chaoui R et al., UOG 2009

Intra- and interoperator reliability of manual and semi-automated measurements of intracranial translucency Karl et al., UOG 2012 Retrospective; 116 stored images at 11–13 weeks; IT measurement Objective Examine whether the assessment of IT at 11–13 weeks can be further standardized by using the semi-automated NT algorithm, SonoNT®, in comparison to manual measurement.

Methodology 11–13 weeks Mid-sagittal plane Dorsoposterior position Two experienced operators Twice manually and twice using the semi-automated software (SonoNT®) Intraoperator and interoperator repeatability BS,brainstem; f.CM, future cisterna magna; OB,occipital bone; Plex.chor., choroid plexus; Th, Thalamus.

Manual Semi-automated The mean of the two manual measurements of the more experienced operator 2 was considered the ‘gold standard’.

Methodology - manual measurement Magnify the image Place the cursor on the inner border of the echogenic posterior brainstem border and on the inner border of the 4th ventricle choroid plexus The longest vertical distance in the middle portion

Methodology – semi-automated Corresponding ‘edge enhancement image’ that reflects the differences  in brightness rather than the brightness itself  Define the echogenic lines delineating the translucency Calipers placed automatically on the inner borders (inner–inner) Left and central images show semi-automated measurement of nuchal translucency, Moratalla J et al., UOG 2010

Methodology – semi-automated The measurement algorithm connects every point on one of the two echogenic lines to all points on the other line, then selects the minimum distance for each point From these minimum distances, it selects the largest as the final translucency measurement Left and central images show semi-automated measurement of nuchal translucency, Moratalla J et al., UOG 2010

IT vs NT semi-automated measurement IT has a more complex shape Risk of incorrect recognition of borders due to neighbouring structures Vertical borders close to the echogenic edges of the brainstem and choroid plexus Lateral borders rather narrow over the IT region Square frame rather than rectangular Smaller frame Moratalla J et al., UOG 2010

Results Manual Semi-automated 0.091 0.088 0.054 0.067 0.940 0.939 Intraoperator SD (mm) 0.091 Median (IQR) (mm) 2.1 (1.9–2.4) Operator 1 Manual 0.088 2.1 (1.8–2.3) Operator 2 0.054 2.2 (1.9–2.4) Semi-automated 0.067 2.2 (1.8-2.2) Intraclass correlation 0.940 0.939 0.982 0.971 Mean difference (mm) –0.09 Reference* 0.01 *The mean of the two manual measurements of operator 2 was considered the ‘gold standard’.

Results 95% limits of agreement Manual Semi-automated –0.26 and 0.23 mm Manual –0.17 and 0.17 mm Semi-automated Interoperator & intermethod* –0.34 and 0.17 mm –0.20 and 0.23 mm Intraoperator Good overall agreement with a trend towards larger measurements using the semi-automated approach *versus the gold standard (the mean of the two manual measurements of operator 2 ).

Strengths Limitations Intra- and interoperator reliability of manual and semi-automated measurements of intracranial translucency Karl et al., UOG 2012 Strengths SonoNT can be used reliably for IT Benefit for less experienced operators High repeatability Limitations Unknown reliability with variations in gestation and anatomy Possible misdiagnosis of Blake’s pouch cyst as spina bifida

Conclusion Manual IT measurements are reproducible Intra- and interoperator reliability of manual and semi-automated measurements of intracranial translucency Karl et al., UOG 2012 Conclusion Manual IT measurements are reproducible IT can be assessed reliably using the semi-automated NT algorithm, leading to standardization of the IT assessment process